Mirae Asset Global Etfs Holdings Ltd. Poseida Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 173,112 shares of PSTX stock, worth $607,623. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173,112Holding current value
$607,623% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PSTX
# of Institutions
95Shares Held
38.1MCall Options Held
417KPut Options Held
42.7K-
Pentwater Capital Management LP Naples, FL5.98MShares$21 Million0.23% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$17.2 Million0.0% of portfolio
-
Boxer Capital, LLC San Diego, CA4.48MShares$15.7 Million0.73% of portfolio
-
Silverarc Capital Management, LLC3.61MShares$12.7 Million2.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.41MShares$12 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $301M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...